These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. Ghigo E; Goffi S; Nicolosi M; Arvat E; Valente F; Mazza E; Ghigo MC; Camanni F J Clin Endocrinol Metab; 1990 Dec; 71(6):1481-5. PubMed ID: 2229304 [TBL] [Abstract][Full Text] [Related]
9. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. Arvat E; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341 [TBL] [Abstract][Full Text] [Related]
10. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity. Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741 [TBL] [Abstract][Full Text] [Related]
11. In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose. Maccario M; Procopio M; Grottoli S; Oleandri SE; Razzore P; Camanni F; Ghigo E J Clin Endocrinol Metab; 1995 Dec; 80(12):3774-8. PubMed ID: 8530634 [TBL] [Abstract][Full Text] [Related]
12. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine. Valcavi R; Valente F; Dieguez C; Zini M; Procopio M; Portioli I; Ghigo E J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770 [TBL] [Abstract][Full Text] [Related]
13. Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. Ghigo E; Procopio M; Boffano GM; Arvat E; Valente F; Maccario M; Mazza E; Camanni F Metabolism; 1992 May; 41(5):560-3. PubMed ID: 1588839 [TBL] [Abstract][Full Text] [Related]
14. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus. Reichardt B; Schrader M; Mojto J; Mehltretter G; Müller OA; Schopohl J J Clin Endocrinol Metab; 1996 May; 81(5):1994-8. PubMed ID: 8626871 [TBL] [Abstract][Full Text] [Related]
15. Low circulating IGF-I levels in hyperthyroidism are associated with decreased GH response to GH-releasing hormone. Ramos-Dias JC; Yateman M; Camacho-Hübner C; Grossman A; Lengyel AM Clin Endocrinol (Oxf); 1995 Nov; 43(5):583-9. PubMed ID: 8548943 [TBL] [Abstract][Full Text] [Related]
16. Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity. Maccario M; Procopio M; Grottoli S; Oleandri SE; Boffano GM; Taliano M; Camanni F; Ghigo E Metabolism; 1996 Mar; 45(3):342-6. PubMed ID: 8606641 [TBL] [Abstract][Full Text] [Related]
17. In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion. Grottoli S; Procopio M; Maccario M; Zini M; Oleandri SE; Tassone F; Valcavi R; Ghigo E J Clin Endocrinol Metab; 1997 Jul; 82(7):2261-5. PubMed ID: 9215304 [TBL] [Abstract][Full Text] [Related]
18. Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocorticoid treatment. Giustina A; Girelli A; Bossoni S; Legati F; Schettino M; Wehrenberg WB Metabolism; 1992 May; 41(5):548-51. PubMed ID: 1375312 [TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH) profiles with successive provocation by GH-releasing hormone and arginine in children: a clinical appraisal. Sato T; Igarashi N; Miyagawa K; Shimizu M; Nishikawa T Endocrinol Jpn; 1991 Feb; 38(1):33-8. PubMed ID: 1915111 [TBL] [Abstract][Full Text] [Related]
20. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans. Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]